CAMP4 Therapeutics Corporation
CAMP
NASDAQ·Healthcare·Biotechnology·Mkt cap $88.1M
$4.15
▲ +0.24%
P/E
-1.86
Mkt Cap
$88.1M
52-Wk Range
$1.41–$7.75
52-Week Range
$1.41 - $7.75
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 166.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary epigenetic screening and discovery platform
- Scientific leadership from top-tier research institutions
- Novel mechanism of action approaches
- Strong intellectual property portfolio
Bear Case
1 risk
- Low volatility (beta 0.2).
Growth
Strong growth ahead
Clinical trial advancement of pipeline candidates
Value
Deep value opportunity - significant discount to Biotech & Therapeutics peers
Momentum
Weak
-5.5% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CAMP right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 13, 2026
Reported EPS of -$0.58 vs -$0.21 consensus (-174.3% surprise). Revenue of $1.8M vs $1.6M expected (+9.8%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-174.3%
Revenue trend · last 8Q
—
—
—
—
—
-47%
+51%
-100%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$652.0K
$858.0K
$1.5M
$795.0K
$348.0K
$1.3M
$0
Margins · last 8Q
Gross
—
Profit
—
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Piper Sandler · Aug 14, 2026
vs Industry
How CAMP stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related